Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Old API Wind-down Ltd - Ordinary Shares ARLZQ

"Old API Wind-down Ltd, formerly Aralez Pharmaceuticals Inc is a specialty pharmaceutical company. The company is engaged in the acquisition, development, and commercialization of products primarily in cardiovascular, pain management and other specialty areas. Its key products include Fiorinal, Proferrin, Fibricor, Uracyst and Neovisc, Cambia and other marketed products. The company currently operates in two geographical markets, the United States and Canada. The firm generates most of its reven


OTCPK:ARLZQ - Post by User

Comment by kuatoliveson Jun 08, 2016 5:07pm
71 Views
Post# 24948171

RE:Bought more. Couldn't help myself

RE:Bought more. Couldn't help myselfWho knows. I don't lose any sleep over trading based on nothing, it always goes in circles. Nowadays I just check my morning email to see if Yosprala has been approved, and if not, glance in a couple of times a day to check the price.

ARLZ is still the most attractive of the pharmas IMO. Valeant and CXR have turned into casino plays, Merus continues to do absolutely nothing, PHM and NHC are still aggregates of cr@p assets, Knight is still a glorified bank account masquerading as a pharma (until they actually do somethig with their money), and the research pharmas are another cross your fingers cr@pshoot. This company is well positioned for growth.

<< Previous
Bullboard Posts
Next >>